@FierceMedDev: GE snags ultrasound repair business. More | Follow @FierceMedDev
@DamianFierce: As GSK trumpets two new FDA approvals, France's bioMérieux is poised to cash in on companion diagnostics. More | Follow @DamianFierce
@MichaelGFierce: Devicemakers balk at FDA's recall guidelines. Item | Follow @MichaelGFierce
> Australian medical device outfit Uscom is buying New Zealand's Pulsecor in exchange for 5 million shares, acquiring the company's BP Plus cardiovascular diagnostic system. News
> Theranostics Health and med fusion are planning to launch their TheraLink assays for breast cancer at this weekend's American Society of Clinical Oncology annual meeting. Story
> Breathe Technologies won FDA clearance for its Sleep System, designed to treat obstructive sleep apnea. More
> Japan could be key for devicemakers looking to profit off of transcatheter aortic valves, led by Edwards Lifesciences ($EW), and Millennium Research Group predicts a rapid adoption of the implants once they hit the market this year. Report
> Boston Scientific ($BSX) has joined the World Stroke Organization, aiming to raise awareness of treatments for atrial fibrillation and other causes of strokes. Item
> Medtronic ($MDT) won FDA approval for the Endurant II AUI stent graft system and 510(k) clearance for the Sentrant introducer sheath. News
> Invacare ($IVC) has amended its credit agreement, giving the company some flexibility as it works its way out from under an FDA warning letter concerning its wheelchair manufacturing. Release
Biotech News
@FierceBiotech: UCLA slams the door on GlaxoSmithKline's latest R&D competition. More | Follow @FierceBiotech
@JohnCFierce: ICYMI: Updated: GlaxoSmithKline gains FDA OK on two genetically targeted melanoma drugs. Report | Follow @JohnCFierce
@RyanMFierce: Biogen Idec appears to be playing the long game with delayed EU launch of Tecfidera, and that could benefit even short-term investors. | Follow @RyanMFierce
@EmilyMFierce: Newest feature at @FierceBiotech: Top 10 experimental cancer drugs - 2013. Special Report | Follow @EmilyMFierce
> San Diego biotech files $23M IPO for gastroparesis PhIII. Report
> Pfizer taps UCSF for small-molecule drug discovery. Story
> ASCO presentations portend future shock of immunotherapy drug prices. Article
> Elan execs ready fallback plan as Royalty attacks 'jumble' of deals. News
Pharma News
@FiercePharma: UK cost watchdog about-faces on BMS and AZN's Forxiga, recommending it for some diabetes patients. Story | Follow @FiercePharma
@EricPFierce: Will Hospira never learn? FDA warning letter says some problems at India plant same as those recently noted at Rocky Mount. More | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: FDA is importing TPN to ease drug shortage. Story | Follow @CarlyHFierce
> Continuing its manufacturing revamp, Pfizer unloads another Tennessee plant. Report
> Bristol-Myers, AstraZeneca win turnabout at NICE for Forxiga. More
> GlaxoSmithKline nabs key FDA approvals for two melanoma drugs. Article
> Ibuprofen carries heart attack, stroke risks on par with Vioxx's at high doses. News
Pharma Manufacturing News
> Pfizer sells King Pharma plant to UPM Pharmaceuticals. More
> UCB sells New York plant to Unither. News
> FDA turns to Fresenius to help relieve TPN shortage. Story
> New problems with Hospira's Indian plant reminiscent of Rocky Mount. Article
> J&J appeals OTC plant license revocation in India. Item
Vaccines News
> H7N9 shows resistance to Roche's Tamiflu. News
> Chinese HFMD vaccine impresses in Phase III. Report
> Gates-inspired gene therapy gives pandemic protection. Story
> Study links GSK's swine flu vaccine to narcolepsy in adults. Article
> Researchers seek fresh approach to HIV vaccine. More
